Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 2

2(25.0%)

Phase 1

1(12.5%)

8Total

N/A(5)

Phase 2(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07441928Not ApplicableRecruiting

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

Role: collaborator

NCT04878198Not ApplicableCompleted

Treatment of Sleep Disturbance in Children With ASD

Role: collaborator

NCT04091139Phase 2Completed

Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong

Role: collaborator

NCT02983188Phase 2Completed

Berberine as Adjuvant Treatment for Schizophrenia Patients

Role: collaborator

NCT00919620Not ApplicableCompleted

Stage-specific Case Management for Early Psychosis

Role: collaborator

NCT02391649Not ApplicableCompleted

Problem-solving-based Bibliotherapy Program for Family Caregivers

Role: collaborator

NCT02453217Not ApplicableCompleted

The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial

Role: collaborator

NCT01780116Phase 1Completed

Effectiveness of Adherence Therapy for Schizophrenia

Role: collaborator

NCT01423669Unknown

Epidemiology Study of Psychosis

Role: collaborator

All 9 trials loaded